Moore Capital Management, LP Alnylam Pharmaceuticals, Inc. Transaction History

Moore Capital Management, LP

  • $4.85 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$151.41 - $196.57 $2.63 Million - $3.41 Million
-17,350 Reduced 78.92%
4,635 $887,000
Q3 2023

Nov 14, 2023
BUY
$170.77 - $211.65 $3.75 Million - $4.65 Million
21,985 New
21,985 $3.89 Million
Q4 2022

Feb 14, 2023
SELL
$185.53 - $241.31 $2.09 Million - $2.71 Million
-11,247 Reduced 52.93%
10,000 $2.38 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $2.94 Million - $4.93 Million
21,247 New
21,247 $4.25 Million

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email